Adverse events24

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 24

Type	Event	Organ system	Group	Affected	At risk
other	abdominal pain	Gastrointestinal disorders	Dalantercept 0.4 mg/kg Plus Sorafenib	6	16
other	abdominal pain	Gastrointestinal disorders	Dalantercept 0.6 mg/kg Plus Sorafenib	1	5
other	peripheral oedema	General disorders	Dalantercept 0.4 mg/kg Plus Sorafenib	4	16
other	peripheral oedema	General disorders	Dalantercept 0.6 mg/kg Plus Sorafenib	2	5
other	pulmonary oedema	Respiratory, thoracic and mediastinal disorders	Dalantercept 0.4 mg/kg Plus Sorafenib	0	16
other	pulmonary oedema	Respiratory, thoracic and mediastinal disorders	Dalantercept 0.6 mg/kg Plus Sorafenib	1	5
other	leukopoenia	Blood and lymphatic system disorders	Dalantercept 0.4 mg/kg Plus Sorafenib	3	16
other	leukopoenia	Blood and lymphatic system disorders	Dalantercept 0.6 mg/kg Plus Sorafenib	1	5
other	asthenia	General disorders	Dalantercept 0.4 mg/kg Plus Sorafenib	2	16
other	asthenia	General disorders	Dalantercept 0.6 mg/kg Plus Sorafenib	0	5
other	pleural effusion	Respiratory, thoracic and mediastinal disorders	Dalantercept 0.4 mg/kg Plus Sorafenib	1	16
other	pleural effusion	Respiratory, thoracic and mediastinal disorders	Dalantercept 0.6 mg/kg Plus Sorafenib	0	5
serious	abdominal pain	Gastrointestinal disorders	Dalantercept 0.4 mg/kg Plus Sorafenib	2	16
serious	abdominal pain	Gastrointestinal disorders	Dalantercept 0.6 mg/kg Plus Sorafenib	2	5
serious	atrial fibrillation	Cardiac disorders	Dalantercept 0.4 mg/kg Plus Sorafenib	1	16
serious	atrial fibrillation	Cardiac disorders	Dalantercept 0.6 mg/kg Plus Sorafenib	1	5
serious	haemoptysis	Respiratory, thoracic and mediastinal disorders	Dalantercept 0.4 mg/kg Plus Sorafenib	1	16
serious	haemoptysis	Respiratory, thoracic and mediastinal disorders	Dalantercept 0.6 mg/kg Plus Sorafenib	0	5
serious	pulmonary oedema	Respiratory, thoracic and mediastinal disorders	Dalantercept 0.4 mg/kg Plus Sorafenib	1	16
serious	pulmonary oedema	Respiratory, thoracic and mediastinal disorders	Dalantercept 0.6 mg/kg Plus Sorafenib	0	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02024087/events

API reference For AI assistants

Adverse events24

Sources 3

Read this list from software.